Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-12-14 21:06:35
Reporting Period:
Accepted Time:
2018-12-14 21:06:35
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1281895 Rocket Pharmaceuticals Inc. RCKT () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251553 P David Southwell C/o Rocket Pharmaceuticals, Inc.
350 Fifth Avenue, Suite 7530
New York NY 10118
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-13 38,768 $15.19 95,160 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. The reported sales were made for the sole purpose of fulfilling the reporting person's tax obligations in connection with the settlement of restricted stock units.
  2. This transaction was executed in multiple trades at prices ranging from $15.00 to $15.80. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.